Case number 1:18-cv-01895
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 22 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 1 | Complaint (21) |
| May 14, 2020 | 55 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of Dismissal)(mdb) |
| May 14, 2020 | 55 | Stipulation of Dismissal (2) |
| May 14, 2020 | 55 | Patent/Trademark Report to Commissioner (1) |
| May 14, 2020 | 54 | SO ORDERED (2) Docket Text: SO ORDERED re [53] Stipulation of Dismissal. ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 5/14/2020. (dlw) |
| May 14, 2020 | 53 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal (and proposed Order) by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| May 6, 2020 | 52 | Redacted Document (3) Docket Text: REDACTED VERSION of [51] Letter by Duchesnay Inc.. (Silver, Daniel) |
| Apr 30, 2020 | N/A | SO ORDERED (0) |
| Mar 3, 2020 | 50 | Redacted Document (3) Docket Text: REDACTED VERSION of [49] Letter by Duchesnay Inc.. (Silver, Daniel) |
| Mar 2, 2020 | N/A | SO ORDERED (0) |
| Jan 6, 2020 | 48 | Redacted Document (3) Docket Text: REDACTED VERSION of [47] Letter by Duchesnay Inc.. (Silver, Daniel) |
| Jan 2, 2020 | N/A | SO ORDERED (0) |
| Nov 20, 2019 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Duchesnays Objections and Responses to Defendants Interrogatories Nos. 13-16 filed by Duchesnay Inc..(Silver, Daniel) |
| Nov 20, 2019 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Actavis Laboratories FL, Inc. And Teva Pharmaceuticals USA, Inc. Notice of Deposition of Michael Gallo 2) Actavis Laboratories FL, Inc. And Teva Pharmaceuticals USA, Inc. Notice of Deposition of Jean-Luc St. Onge 3) Actavis Laboratories FL, Inc. And Teva Pharmaceuticals USA, Inc. Notice of Deposition of Christelle Gedeon 4) Actavis Laboratories FL, Inc. And Teva Pharmaceuticals USA, Inc. Notice of Deposition of Eric Gervais 5) Actavis Laboratories FL, Inc. And Teva Pharmaceuticals USA, Inc. Notice of Deposition of Manon Vranderick filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 14, 2019 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Notice of Deposition to Plaintiff Duchesnay Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 13, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the 11/13/2020 pretrial conference and 3-day bench trial set for 11/30/2020 shall now be held in Courtroom 4A. All other provisions of the 2/13/2019 Scheduling Order [19] shall remain in full force unless superseded by this Court's form Scheduling Order or by Stipulation and Order. ORDERED by Judge Maryellen Noreika on 11/13/2019. (dlw) |
| Nov 12, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Nov 4, 2019 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 29, 2019 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Plaintiff Duchesnay Inc.'s First Supplemental Response to Defendants' Second Set of Interrogatories (Nos. 9-12), and (ii) Plaintiff Duchesnay Inc.'s First Supplemental Objections and Responses to Defendants' Interrogatories Nos. 5, 6 filed by Duchesnay Inc..(Silver, Daniel) |
| Oct 21, 2019 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Third Set of Interrogatory Requests to Plaintiff (Nos. 13-16) filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 6, 2019 | 39 | Order (3) Docket Text: SO ORDERED Granting [38] Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 9/6/2019. (nms) |
| Sep 6, 2019 | 38 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction by Duchesnay Inc.. (Silver, Daniel) |
| Aug 23, 2019 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Duchesnay's List of Claim Terms to be Construed filed by Duchesnay Inc..(Silver, Daniel) |
| Aug 1, 2019 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-6) filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 22, 2019 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Duchesnay's Response to Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.'s Second Set of Interrogatories (Nos. 9-12) and (2) Duchesnay's Response to Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.'s Second Set of Requests for Documents and Thins (Nos. 67-68) filed by Duchesnay Inc..(Silver, Daniel) |
| Jun 21, 2019 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendants Second Set of Interrogatory Requests to Plaintiff (Nos. 9-12) 2. Defendants Second Set of Requests to Plaintiff for the Production of Documents and Things (Nos. 67-68) 3. Defendants Initial Invalidity Contentions filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| May 22, 2019 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Duchesnays Response to Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.s First Set of Interrogatories (Nos. 1-8) and (2) Duchesnays Response to Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.s First Set of Requests for Documents and Things (Nos. 1-66) filed by Duchesnay Inc..(Silver, Daniel) |
| May 13, 2019 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Objections and Responses to Plaintiffs First Set of Requests for Production of Documents and Things (Nos. 1-34); and (2) Defendants Objections and Responses to Plaintiffs First Set of Interrogatory Requests (Nos. 16) filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| May 10, 2019 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Infringement Contentions filed by Duchesnay Inc..(Silver, Daniel) |
| Apr 22, 2019 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Set of Requests to Plaintiff for the Production of Documents and Things (Nos. 1-66) (2) Defendants' First Set of Interrogatory Requests to Plaintiff (Nos. 1-8) filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Apr 12, 2019 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Duchesnay Inc.s First Set of Requests for Production of Documents and Things (Nos. 1-34) to Defendants Actavis Laboratories Fl, Inc. and Teva Pharmaceuticals USA, Inc., and (2) Plaintiff Duchesnay Inc.s First Interrogatories (Nos. 1-6) to Defendants Actavis Laboratories Fl, Inc. and Teva Pharmaceuticals USA, Inc. filed by Duchesnay Inc..(Silver, Daniel) |
| Mar 29, 2019 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Duchesnay Inc..(Silver, Daniel) |
| Mar 29, 2019 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Mar 13, 2019 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Actavis Laboratories FL, Inc. and Teva Pharmaceuticals USA, Inc.'s Rule 26(a) Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Mar 13, 2019 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Duchesnay Inc..(Silver, Daniel) |
| Mar 6, 2019 | 23 | Proposed Order (21) Docket Text: PROPOSED Stipulated Protective Order, by Duchesnay Inc.. (Silver, Daniel) Modified on 3/6/2019 (nms). |
| Mar 6, 2019 | 24 | Order (21) Docket Text: SO ORDERED Granting [23] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 3/6/2019. (nms) |
| Mar 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Benjamin T. Hemmelgarn for Duchesnay Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Mar 4, 2019 | N/A | SO ORDERED (0) |
| Mar 4, 2019 | 22 | Certification by Counsel to Be Admitted Pro Hac (1) |
| Mar 4, 2019 | 22 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Benjamin T. Hemmelgarn - filed by Duchesnay Inc.. (Attachments: # (1) Certification)(Silver, Daniel) Modified on 3/4/2019 (nms). |
| Feb 19, 2019 | 21 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: plaintiffs counsel shall initiate the call. A Telephone Conference is set for 3/11/2019 at 11:30 AM before Judge Sherry R. Fallon to discuss ADR. Signed by Judge Sherry R. Fallon on 2/19/2019. (lih) |
| Feb 13, 2019 | N/A | Oral Order (0) |
| Feb 13, 2019 | 19 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/28/2020. Amended Pleadings due by 2/28/2020. Fact Discovery completed by 3/20/2020. Joint Claim Construction Brief due by 12/17/2019. A Markman Hearing is set for 1/30/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 11/13/2020, at 2:00 PM in Courtroom 6A. A 3 day Bench Trial is set for 11/30/2020, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/13/2019. (nms) |
| Feb 13, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Feb 12, 2019 | 18 | Proposed Order (9) Docket Text: PROPOSED Scheduling Order, by Duchesnay Inc.. (Silver, Daniel) Modified on 2/12/2019 (nms). |
| Feb 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Feb 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 30, 2019 | 17 | Answer to Counterclaim (10) Docket Text: ANSWER to [13] Answer to Complaint, Counterclaim by Duchesnay Inc..(Silver, Daniel) |
| Jan 23, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 14, 2019 | 16 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 2/27/2019, at 2:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/14/2019. (nms) |
| Jan 9, 2019 | 15 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals USA, Inc., Other Affiliate Teva Pharmaceutical Industries Ltd. for Actavis Laboratories FL, Inc. filed by Actavis Laboratories FL, Inc.. (Keller, Karen) |
| Jan 9, 2019 | 14 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Jan 9, 2019 | 13 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Duchesnay Inc., by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) Modified on 1/9/2019 (nms). |
| Jan 7, 2019 | N/A | SO ORDERED (0) |
| Jan 7, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay P. Lefkowitz - filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | N/A | SO ORDERED (0) |
| Dec 18, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeanna Wacker, Jessica Lam, and Ashley L. Ross - filed by Actavis Laboratories FL, Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Dec 18, 2018 | 10 | Certifications (3) |
| Dec 18, 2018 | 10 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Barbara R. Rudolph, Danielle A. Duszczyszyn, and Cora R. Holt - filed by Duchesnay Inc.. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 12/19/2018 (nms). |
| Dec 14, 2018 | 9 | Order (5) Docket Text: SO ORDERED Granting [8] Stipulation and Order Dismissing Without Prejudice Defendant Teva Pharmaceutical Industries Ltd. (*Party Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 12/13/2018. (nms) |
| Dec 13, 2018 | 8 | Stipulation of Dismissal (5) Docket Text: STIPULATION and Order Dismissing Without Prejudice of [Teva Pharmaceutical Industries Ltd., by Teva Pharmaceutical Industries Ltd.. (Hoeschen, Nathan) Modified on 12/13/2018 (nms). |
| Dec 13, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Duchesnay Inc.: For Actavis Laboratories FL, Inc. waiver sent on 12/12/2018, answer due 2/11/2019. (Silver, Daniel) |
| Dec 13, 2018 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Duchesnay Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 12/12/2018, answer due 2/11/2019. (Silver, Daniel) |
| Dec 6, 2018 | N/A | Case Assigned/Reassigned (0) |
| Nov 30, 2018 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (ceg) |
| Nov 29, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Duchesnay Inc. (ceg) |
| Nov 29, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,089,489; 9,375,404; 9,526,703; 9,937,132. (ceg) |
| Nov 29, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/16/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/16/2021. (ceg) |
| Nov 29, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Nov 29, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 29, 2018 | 1 | Main Document (21) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis Laboratories FL, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2514277.) - filed by Duchesnay Inc. (Attachments: # (1) Exhibits A-D, # (2) Civil Cover Sheet)(ceg) |
| Nov 29, 2018 | 1 | Exhibits A-D (148) |
| Nov 29, 2018 | 1 | Complaint* (1) |
